

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | fusion of sperm to egg plasma membrane (GO:0007342) | 5.19507351 |
| 2 | type I interferon signaling pathway (GO:0060337) | 4.98100703 |
| 3 | cellular response to type I interferon (GO:0071357) | 4.98100703 |
| 4 | response to type I interferon (GO:0034340) | 4.92592085 |
| 5 | sperm motility (GO:0030317) | 4.89911410 |
| 6 | cilium or flagellum-dependent cell motility (GO:0001539) | 4.69652030 |
| 7 | response to peptidoglycan (GO:0032494) | 4.62365927 |
| 8 | neutrophil activation involved in immune response (GO:0002283) | 4.59727022 |
| 9 | macrophage activation involved in immune response (GO:0002281) | 4.55650062 |
| 10 | regulation of interferon-alpha production (GO:0032647) | 4.47152147 |
| 11 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.34983973 |
| 12 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.27880633 |
| 13 | positive regulation of interferon-alpha production (GO:0032727) | 4.21747906 |
| 14 | negative regulation of interleukin-12 production (GO:0032695) | 4.11185013 |
| 15 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.05950633 |
| 16 | plasma membrane fusion (GO:0045026) | 4.05562841 |
| 17 | acrosome assembly (GO:0001675) | 4.04400772 |
| 18 | lens development in camera-type eye (GO:0002088) | 3.99407986 |
| 19 | acrosome reaction (GO:0007340) | 3.99369554 |
| 20 | modulation by symbiont of host defense response (GO:0052031) | 3.98459456 |
| 21 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.98459456 |
| 22 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.98459456 |
| 23 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.98459456 |
| 24 | modulation by symbiont of host immune response (GO:0052553) | 3.98459456 |
| 25 | positive regulation by symbiont of host defense response (GO:0052509) | 3.98459456 |
| 26 | multicellular organism reproduction (GO:0032504) | 3.93309744 |
| 27 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.91931006 |
| 28 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.88725413 |
| 29 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.82236966 |
| 30 | low-density lipoprotein particle clearance (GO:0034383) | 3.78684667 |
| 31 | detection of molecule of bacterial origin (GO:0032490) | 3.77761900 |
| 32 | cell wall macromolecule metabolic process (GO:0044036) | 3.71979027 |
| 33 | cell wall macromolecule catabolic process (GO:0016998) | 3.71979027 |
| 34 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.70574957 |
| 35 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.69277043 |
| 36 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.68267690 |
| 37 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 3.66471693 |
| 38 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.66165188 |
| 39 | response to interferon-alpha (GO:0035455) | 3.59648676 |
| 40 | rhodopsin mediated signaling pathway (GO:0016056) | 3.56966167 |
| 41 | reproduction (GO:0000003) | 3.56763563 |
| 42 | immunoglobulin mediated immune response (GO:0016064) | 3.56500666 |
| 43 | positive regulation of type 2 immune response (GO:0002830) | 3.55648969 |
| 44 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.54888908 |
| 45 | sperm-egg recognition (GO:0035036) | 3.54528057 |
| 46 | T-helper 1 type immune response (GO:0042088) | 3.53226997 |
| 47 | macroautophagy (GO:0016236) | 3.51479602 |
| 48 | piRNA metabolic process (GO:0034587) | 3.49817370 |
| 49 | negative regulation of cell killing (GO:0031342) | 3.45744477 |
| 50 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.45744477 |
| 51 | cellular response to interferon-alpha (GO:0035457) | 3.42774310 |
| 52 | detection of other organism (GO:0098543) | 3.42561586 |
| 53 | negative regulation of viral genome replication (GO:0045071) | 3.38971477 |
| 54 | positive regulation of interferon-beta production (GO:0032728) | 3.30165416 |
| 55 | cell-cell recognition (GO:0009988) | 3.27416109 |
| 56 | regulation of vitamin metabolic process (GO:0030656) | 3.25826221 |
| 57 | plasma lipoprotein particle clearance (GO:0034381) | 3.25629383 |
| 58 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.25096362 |
| 59 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.23966050 |
| 60 | detection of external biotic stimulus (GO:0098581) | 3.22967839 |
| 61 | defense response to protozoan (GO:0042832) | 3.20336376 |
| 62 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.18871295 |
| 63 | axonemal dynein complex assembly (GO:0070286) | 3.18751415 |
| 64 | granulocyte activation (GO:0036230) | 3.17603191 |
| 65 | alpha-linolenic acid metabolic process (GO:0036109) | 3.15721668 |
| 66 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.14598650 |
| 67 | binding of sperm to zona pellucida (GO:0007339) | 3.14165089 |
| 68 | germinal center formation (GO:0002467) | 3.13832921 |
| 69 | spermatid development (GO:0007286) | 3.13576166 |
| 70 | detection of bacterium (GO:0016045) | 3.13130786 |
| 71 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.12676973 |
| 72 | epithelial cilium movement (GO:0003351) | 3.10085081 |
| 73 | regulation of type 2 immune response (GO:0002828) | 3.09200845 |
| 74 | visual perception (GO:0007601) | 3.08314534 |
| 75 | NIK/NF-kappaB signaling (GO:0038061) | 3.07811257 |
| 76 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.07168292 |
| 77 | response to muramyl dipeptide (GO:0032495) | 3.06533665 |
| 78 | regulation of chemokine biosynthetic process (GO:0045073) | 3.06015935 |
| 79 | lens fiber cell development (GO:0070307) | 3.05372503 |
| 80 | myeloid cell activation involved in immune response (GO:0002275) | 3.04830704 |
| 81 | sensory perception of light stimulus (GO:0050953) | 3.04224971 |
| 82 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.02402180 |
| 83 | response to protozoan (GO:0001562) | 3.02359009 |
| 84 | regulation of podosome assembly (GO:0071801) | 3.01454299 |
| 85 | myeloid dendritic cell differentiation (GO:0043011) | 3.00690480 |
| 86 | neutrophil activation (GO:0042119) | 3.00175234 |
| 87 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.00091114 |
| 88 | response to host immune response (GO:0052572) | 2.99903446 |
| 89 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.99903446 |
| 90 | negative regulation of inclusion body assembly (GO:0090084) | 2.99252643 |
| 91 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.97672200 |
| 92 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.97112231 |
| 93 | cellular glucuronidation (GO:0052695) | 2.95361695 |
| 94 | regulation of cholesterol storage (GO:0010885) | 2.94916880 |
| 95 | lipoprotein transport (GO:0042953) | 2.94845997 |
| 96 | motile cilium assembly (GO:0044458) | 2.94410637 |
| 97 | macrophage activation (GO:0042116) | 2.93947643 |
| 98 | T cell migration (GO:0072678) | 2.91957313 |
| 99 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.90884992 |
| 100 | urea cycle (GO:0000050) | 2.89934338 |
| 101 | urea metabolic process (GO:0019627) | 2.89934338 |
| 102 | male meiosis (GO:0007140) | 2.89599223 |
| 103 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.89032678 |
| 104 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.88562832 |
| 105 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.87854335 |
| 106 | reverse cholesterol transport (GO:0043691) | 2.85168825 |
| 107 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.84542037 |
| 108 | cellular response to interferon-gamma (GO:0071346) | 2.83432664 |
| 109 | regulation of RIG-I signaling pathway (GO:0039535) | 2.80676422 |
| 110 | organic cation transport (GO:0015695) | 2.78582192 |
| 111 | uronic acid metabolic process (GO:0006063) | 2.77752256 |
| 112 | glucuronate metabolic process (GO:0019585) | 2.77752256 |
| 113 | detection of biotic stimulus (GO:0009595) | 2.77733699 |
| 114 | response to host (GO:0075136) | 2.76313502 |
| 115 | response to host defenses (GO:0052200) | 2.76313502 |
| 116 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.76313502 |
| 117 | phagocytosis, engulfment (GO:0006911) | 2.75692843 |
| 118 | high-density lipoprotein particle remodeling (GO:0034375) | 2.75472861 |
| 119 | retinal rod cell development (GO:0046548) | 2.74279151 |
| 120 | phototransduction (GO:0007602) | 2.73944693 |
| 121 | phospholipid homeostasis (GO:0055091) | 2.73818744 |
| 122 | phototransduction, visible light (GO:0007603) | 2.73724574 |
| 123 | regulation of interleukin-12 production (GO:0032655) | 2.72293701 |
| 124 | regulation of growth of symbiont in host (GO:0044126) | 2.71373196 |
| 125 | negative regulation of growth of symbiont in host (GO:0044130) | 2.71373196 |
| 126 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.71373196 |
| 127 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.71373196 |
| 128 | carnitine transmembrane transport (GO:1902603) | 2.71304876 |
| 129 | regulation of interferon-beta production (GO:0032648) | 2.71181784 |
| 130 | carnitine transport (GO:0015879) | 2.71060364 |
| 131 | amino-acid betaine transport (GO:0015838) | 2.71060364 |
| 132 | response to interferon-gamma (GO:0034341) | 2.70245816 |
| 133 | cellular response to virus (GO:0098586) | 2.70055764 |
| 134 | regulation of chronic inflammatory response (GO:0002676) | 2.70040260 |
| 135 | detection of light stimulus involved in visual perception (GO:0050908) | 2.70005678 |
| 136 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.70005678 |
| 137 | retinal cone cell development (GO:0046549) | 2.69977287 |
| 138 | synaptonemal complex organization (GO:0070193) | 2.69906663 |
| 139 | complement activation, alternative pathway (GO:0006957) | 2.69715744 |
| 140 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.69246021 |
| 141 | cholesterol efflux (GO:0033344) | 2.69223615 |
| 142 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.68565057 |
| 143 | cilium movement (GO:0003341) | 2.67806922 |
| 144 | B cell mediated immunity (GO:0019724) | 2.67365341 |
| 145 | regulation of protein polyubiquitination (GO:1902914) | 2.67243840 |
| 146 | regulation of T cell tolerance induction (GO:0002664) | 2.66818809 |
| 147 | positive regulation of antigen processing and presentation (GO:0002579) | 2.66020143 |
| 148 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.65854948 |
| 149 | regulation of antigen processing and presentation (GO:0002577) | 2.65804771 |
| 150 | sperm capacitation (GO:0048240) | 2.65471752 |
| 151 | regulation of gamma-delta T cell activation (GO:0046643) | 2.64922194 |
| 152 | cellular response to lipopolysaccharide (GO:0071222) | 2.64663977 |
| 153 | cellular response to molecule of bacterial origin (GO:0071219) | 2.63899477 |
| 154 | myeloid dendritic cell activation (GO:0001773) | 2.63749356 |
| 155 | regulation of triglyceride catabolic process (GO:0010896) | 2.63140210 |
| 156 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.62859146 |
| 157 | regulation of T-helper cell differentiation (GO:0045622) | 2.62110953 |
| 158 | glycosphingolipid catabolic process (GO:0046479) | 2.61833945 |
| 159 | negative regulation of T cell mediated immunity (GO:0002710) | 2.61299857 |
| 160 | detection of light stimulus (GO:0009583) | 2.61215728 |
| 161 | photoreceptor cell development (GO:0042461) | 2.58769458 |
| 162 | nitrogen cycle metabolic process (GO:0071941) | 2.58117755 |
| 163 | synaptonemal complex assembly (GO:0007130) | 2.57195846 |
| 164 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.57061526 |
| 165 | detection of visible light (GO:0009584) | 2.56628667 |
| 166 | bile acid and bile salt transport (GO:0015721) | 2.55245588 |
| 167 | photoreceptor cell maintenance (GO:0045494) | 2.53880870 |
| 168 | phospholipid efflux (GO:0033700) | 2.52826002 |
| 169 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.52614560 |
| 170 | L-phenylalanine catabolic process (GO:0006559) | 2.52614560 |
| 171 | positive regulation of lipid catabolic process (GO:0050996) | 2.52413267 |
| 172 | hormone catabolic process (GO:0042447) | 2.50351617 |
| 173 | positive regulation of guanylate cyclase activity (GO:0031284) | 2.49105396 |
| 174 | plasma lipoprotein particle remodeling (GO:0034369) | 2.46332040 |
| 175 | protein-lipid complex remodeling (GO:0034368) | 2.46332040 |
| 176 | macromolecular complex remodeling (GO:0034367) | 2.46332040 |
| 177 | lipid translocation (GO:0034204) | 2.44676655 |
| 178 | phospholipid translocation (GO:0045332) | 2.44676655 |
| 179 | positive regulation of glycolytic process (GO:0045821) | 2.42630629 |
| 180 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.42544346 |
| 181 | protein carboxylation (GO:0018214) | 2.42544346 |
| 182 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.40748855 |
| 183 | eye photoreceptor cell development (GO:0042462) | 2.39198756 |
| 184 | single fertilization (GO:0007338) | 2.38125196 |
| 185 | L-phenylalanine metabolic process (GO:0006558) | 2.34871129 |
| 186 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.34871129 |
| 187 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 2.31886516 |
| 188 | flavonoid metabolic process (GO:0009812) | 2.29656915 |
| 189 | sexual reproduction (GO:0019953) | 2.28851929 |
| 190 | growth hormone receptor signaling pathway (GO:0060396) | 2.27405720 |
| 191 | fatty acid transmembrane transport (GO:1902001) | 2.26468639 |
| 192 | fructose metabolic process (GO:0006000) | 2.24892716 |
| 193 | protein-lipid complex assembly (GO:0065005) | 2.23707897 |
| 194 | mannose metabolic process (GO:0006013) | 2.23705639 |
| 195 | regulation of protein activation cascade (GO:2000257) | 2.23705414 |
| 196 | cytolysis (GO:0019835) | 2.23000862 |
| 197 | fertilization (GO:0009566) | 2.22191023 |
| 198 | sulfur amino acid catabolic process (GO:0000098) | 2.21574953 |
| 199 | regulation of guanylate cyclase activity (GO:0031282) | 2.20600658 |
| 200 | regulation of cholesterol esterification (GO:0010872) | 2.20180330 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.63834758 |
| 2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.37480878 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.28646489 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.24606704 |
| 5 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.88837616 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.81000449 |
| 7 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.79098482 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.70217420 |
| 9 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.67540825 |
| 10 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.49428688 |
| 11 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.47940890 |
| 12 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.39989832 |
| 13 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.30939388 |
| 14 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.22230417 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.17633603 |
| 16 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.97518319 |
| 17 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.97353748 |
| 18 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.96614851 |
| 19 | SPI1_23127762_ChIP-Seq_K562_Human | 1.89192436 |
| 20 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.83130746 |
| 21 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.80145633 |
| 22 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.78712303 |
| 23 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.74276790 |
| 24 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.71597699 |
| 25 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.65337116 |
| 26 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.64615657 |
| 27 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.62550514 |
| 28 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.62460589 |
| 29 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.61914256 |
| 30 | MYB_26560356_Chip-Seq_TH2_Human | 1.60122264 |
| 31 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.57141921 |
| 32 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.49716064 |
| 33 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.47014767 |
| 34 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.46075374 |
| 35 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.44508279 |
| 36 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.44245828 |
| 37 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43664930 |
| 38 | MAF_26560356_Chip-Seq_TH1_Human | 1.43299993 |
| 39 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.42395364 |
| 40 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.41516868 |
| 41 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.40109006 |
| 42 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.40074076 |
| 43 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.37048850 |
| 44 | MYB_26560356_Chip-Seq_TH1_Human | 1.36852883 |
| 45 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.33451926 |
| 46 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.33167718 |
| 47 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.33006451 |
| 48 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.32682177 |
| 49 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.31026596 |
| 50 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.29891200 |
| 51 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.28174434 |
| 52 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.26200347 |
| 53 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.25418880 |
| 54 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.23473073 |
| 55 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.22231337 |
| 56 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.22074774 |
| 57 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20086549 |
| 58 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.19569356 |
| 59 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.16824919 |
| 60 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.12400949 |
| 61 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11168192 |
| 62 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.09403830 |
| 63 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.08703043 |
| 64 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.08345042 |
| 65 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07311047 |
| 66 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.06216467 |
| 67 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04414662 |
| 68 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04224453 |
| 69 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.03843245 |
| 70 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.03007049 |
| 71 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02916121 |
| 72 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.02865059 |
| 73 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02614436 |
| 74 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.01909685 |
| 75 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.01332733 |
| 76 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00931919 |
| 77 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.00717240 |
| 78 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.00584199 |
| 79 | UTX_26944678_Chip-Seq_JUKART_Human | 1.00576539 |
| 80 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.99855150 |
| 81 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.99547715 |
| 82 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99310427 |
| 83 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.98866345 |
| 84 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.98298461 |
| 85 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.98018928 |
| 86 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97577781 |
| 87 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.97160959 |
| 88 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.96323569 |
| 89 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95979316 |
| 90 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.95149795 |
| 91 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.94237090 |
| 92 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.93949618 |
| 93 | CJUN_26792858_Chip-Seq_BT549_Human | 0.93653947 |
| 94 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.92783249 |
| 95 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92537444 |
| 96 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.92452737 |
| 97 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.92223051 |
| 98 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91997917 |
| 99 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.91799573 |
| 100 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91300945 |
| 101 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.90913026 |
| 102 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.90605356 |
| 103 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.90574122 |
| 104 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.89002278 |
| 105 | GATA3_26560356_Chip-Seq_TH2_Human | 0.87514020 |
| 106 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.87178035 |
| 107 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.87178035 |
| 108 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.86695867 |
| 109 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.86690411 |
| 110 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86286750 |
| 111 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.86163721 |
| 112 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.85859798 |
| 113 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.85859798 |
| 114 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85814926 |
| 115 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.85438654 |
| 116 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.84965765 |
| 117 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.84535896 |
| 118 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.84535896 |
| 119 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.84230990 |
| 120 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.82746768 |
| 121 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.82381032 |
| 122 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.81897279 |
| 123 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.81409994 |
| 124 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.81376790 |
| 125 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.80974246 |
| 126 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.80974246 |
| 127 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80284451 |
| 128 | MAF_26560356_Chip-Seq_TH2_Human | 0.79507614 |
| 129 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.79437776 |
| 130 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.79388154 |
| 131 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.79074390 |
| 132 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.78537798 |
| 133 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.77871657 |
| 134 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77393465 |
| 135 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.77372460 |
| 136 | KDM2B_26808549_Chip-Seq_REH_Human | 0.77139839 |
| 137 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.76885335 |
| 138 | GATA1_19941826_ChIP-Seq_K562_Human | 0.76566210 |
| 139 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.76304012 |
| 140 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.75362282 |
| 141 | GATA2_19941826_ChIP-Seq_K562_Human | 0.74645305 |
| 142 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.73770719 |
| 143 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.73637981 |
| 144 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.73231582 |
| 145 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.73033298 |
| 146 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.72574493 |
| 147 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.71725987 |
| 148 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.71207469 |
| 149 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.70593181 |
| 150 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.70316376 |
| 151 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.69635353 |
| 152 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.69481750 |
| 153 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.69229916 |
| 154 | KDM2B_26808549_Chip-Seq_K562_Human | 0.67307062 |
| 155 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.67001674 |
| 156 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.66723429 |
| 157 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.66589365 |
| 158 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.66470363 |
| 159 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 0.65904575 |
| 160 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.65870476 |
| 161 | GATA1_22025678_ChIP-Seq_K562_Human | 0.65809801 |
| 162 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.65735706 |
| 163 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.64918141 |
| 164 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.64887318 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005410_abnormal_fertilization | 5.22817565 |
| 2 | MP0003011_delayed_dark_adaptation | 4.94581863 |
| 3 | MP0005360_urolithiasis | 3.78245864 |
| 4 | MP0005551_abnormal_eye_electrophysiolog | 3.67314625 |
| 5 | MP0002139_abnormal_hepatobiliary_system | 3.49276585 |
| 6 | MP0005253_abnormal_eye_physiology | 3.21046727 |
| 7 | MP0002254_reproductive_system_inflammat | 2.92971495 |
| 8 | MP0002148_abnormal_hypersensitivity_rea | 2.71117349 |
| 9 | MP0002090_abnormal_vision | 2.60822785 |
| 10 | MP0005365_abnormal_bile_salt | 2.60600795 |
| 11 | MP0005025_abnormal_response_to | 2.55217391 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.50910963 |
| 13 | MP0001790_abnormal_immune_system | 2.50357620 |
| 14 | MP0005387_immune_system_phenotype | 2.50357620 |
| 15 | MP0003252_abnormal_bile_duct | 2.39658396 |
| 16 | MP0005085_abnormal_gallbladder_physiolo | 2.38846440 |
| 17 | MP0005451_abnormal_body_composition | 2.38528149 |
| 18 | MP0005671_abnormal_response_to | 2.37413612 |
| 19 | MP0009840_abnormal_foam_cell | 2.36710361 |
| 20 | MP0002697_abnormal_eye_size | 2.32851961 |
| 21 | MP0010329_abnormal_lipoprotein_level | 2.25080513 |
| 22 | MP0003191_abnormal_cellular_cholesterol | 2.18538463 |
| 23 | MP0008875_abnormal_xenobiotic_pharmacok | 2.17988321 |
| 24 | MP0001800_abnormal_humoral_immune | 2.17636147 |
| 25 | MP0002452_abnormal_antigen_presenting | 2.09710110 |
| 26 | MP0002723_abnormal_immune_serum | 2.07103698 |
| 27 | MP0008004_abnormal_stomach_pH | 2.07056805 |
| 28 | MP0000685_abnormal_immune_system | 1.97659771 |
| 29 | MP0010155_abnormal_intestine_physiology | 1.96742253 |
| 30 | MP0003705_abnormal_hypodermis_morpholog | 1.91567942 |
| 31 | MP0001324_abnormal_eye_pigmentation | 1.85607512 |
| 32 | MP0008260_abnormal_autophagy | 1.80089124 |
| 33 | MP0001819_abnormal_immune_cell | 1.78777185 |
| 34 | MP0002420_abnormal_adaptive_immunity | 1.77169956 |
| 35 | MP0003950_abnormal_plasma_membrane | 1.71793321 |
| 36 | MP0001845_abnormal_inflammatory_respons | 1.70778023 |
| 37 | MP0005193_abnormal_anterior_eye | 1.67368455 |
| 38 | MP0000604_amyloidosis | 1.61125716 |
| 39 | MP0006054_spinal_hemorrhage | 1.59942440 |
| 40 | MP0004233_abnormal_muscle_weight | 1.59770267 |
| 41 | MP0005391_vision/eye_phenotype | 1.57031464 |
| 42 | MP0005195_abnormal_posterior_eye | 1.57001189 |
| 43 | MP0004019_abnormal_vitamin_homeostasis | 1.51605671 |
| 44 | MP0003453_abnormal_keratinocyte_physiol | 1.51113736 |
| 45 | MP0003300_gastrointestinal_ulcer | 1.50863386 |
| 46 | MP0005167_abnormal_blood-brain_barrier | 1.46435795 |
| 47 | MP0005310_abnormal_salivary_gland | 1.44912199 |
| 48 | MP0002405_respiratory_system_inflammati | 1.44773847 |
| 49 | MP0003690_abnormal_glial_cell | 1.44725420 |
| 50 | MP0003303_peritoneal_inflammation | 1.42853981 |
| 51 | MP0001853_heart_inflammation | 1.42825878 |
| 52 | MP0005058_abnormal_lysosome_morphology | 1.41721049 |
| 53 | MP0002998_abnormal_bone_remodeling | 1.41061993 |
| 54 | MP0001666_abnormal_nutrient_absorption | 1.40892194 |
| 55 | MP0003698_abnormal_male_reproductive | 1.40715248 |
| 56 | MP0000465_gastrointestinal_hemorrhage | 1.40304392 |
| 57 | MP0005670_abnormal_white_adipose | 1.39487240 |
| 58 | MP0006072_abnormal_retinal_apoptosis | 1.39069793 |
| 59 | MP0002118_abnormal_lipid_homeostasis | 1.38742942 |
| 60 | MP0009333_abnormal_splenocyte_physiolog | 1.38360880 |
| 61 | MP0003075_altered_response_to | 1.35876899 |
| 62 | MP0004130_abnormal_muscle_cell | 1.32749681 |
| 63 | MP0003448_altered_tumor_morphology | 1.32367425 |
| 64 | MP0003436_decreased_susceptibility_to | 1.31408505 |
| 65 | MP0000569_abnormal_digit_pigmentation | 1.31183145 |
| 66 | MP0000343_altered_response_to | 1.30763591 |
| 67 | MP0000716_abnormal_immune_system | 1.28808189 |
| 68 | MP0010352_gastrointestinal_tract_polyps | 1.28399844 |
| 69 | MP0000609_abnormal_liver_physiology | 1.26931372 |
| 70 | MP0005197_abnormal_uvea_morphology | 1.25855086 |
| 71 | MP0001764_abnormal_homeostasis | 1.24407617 |
| 72 | MP0003763_abnormal_thymus_physiology | 1.24098770 |
| 73 | MP0000858_altered_metastatic_potential | 1.21547120 |
| 74 | MP0010234_abnormal_vibrissa_follicle | 1.20670801 |
| 75 | MP0002332_abnormal_exercise_endurance | 1.19337633 |
| 76 | MP0001545_abnormal_hematopoietic_system | 1.19257932 |
| 77 | MP0005397_hematopoietic_system_phenotyp | 1.19257932 |
| 78 | MP0002166_altered_tumor_susceptibility | 1.18502582 |
| 79 | MP0002398_abnormal_bone_marrow | 1.16497756 |
| 80 | MP0003656_abnormal_erythrocyte_physiolo | 1.16180403 |
| 81 | MP0003724_increased_susceptibility_to | 1.15649217 |
| 82 | MP0002168_other_aberrant_phenotype | 1.13704711 |
| 83 | MP0004510_myositis | 1.12656119 |
| 84 | MP0005319_abnormal_enzyme/_coenzyme | 1.11986280 |
| 85 | MP0000015_abnormal_ear_pigmentation | 1.09748268 |
| 86 | MP0005666_abnormal_adipose_tissue | 1.09681152 |
| 87 | MP0005083_abnormal_biliary_tract | 1.09472641 |
| 88 | MP0003329_amyloid_beta_deposits | 1.08804759 |
| 89 | MP0003172_abnormal_lysosome_physiology | 1.08779005 |
| 90 | MP0002138_abnormal_hepatobiliary_system | 1.08230176 |
| 91 | MP0001929_abnormal_gametogenesis | 1.08156576 |
| 92 | MP0002229_neurodegeneration | 1.07170397 |
| 93 | MP0010368_abnormal_lymphatic_system | 1.06901667 |
| 94 | MP0002877_abnormal_melanocyte_morpholog | 1.05625682 |
| 95 | MP0005408_hypopigmentation | 1.05531957 |
| 96 | MP0006082_CNS_inflammation | 1.05252262 |
| 97 | MP0003806_abnormal_nucleotide_metabolis | 1.02695684 |
| 98 | MP0001958_emphysema | 1.01408531 |
| 99 | MP0004381_abnormal_hair_follicle | 1.00949322 |
| 100 | MP0001873_stomach_inflammation | 1.00345426 |
| 101 | MP0002006_tumorigenesis | 1.00090182 |
| 102 | MP0002971_abnormal_brown_adipose | 0.99959747 |
| 103 | MP0003045_fibrosis | 0.99901886 |
| 104 | MP0002429_abnormal_blood_cell | 0.96954109 |
| 105 | MP0003828_pulmonary_edema | 0.96824027 |
| 106 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.95900381 |
| 107 | MP0005332_abnormal_amino_acid | 0.95829391 |
| 108 | MP0009764_decreased_sensitivity_to | 0.95050609 |
| 109 | MP0004883_abnormal_blood_vessel | 0.94770633 |
| 110 | MP0001851_eye_inflammation | 0.93896475 |
| 111 | MP0000689_abnormal_spleen_morphology | 0.92853733 |
| 112 | MP0003195_calcinosis | 0.91561040 |
| 113 | MP0002722_abnormal_immune_system | 0.91481816 |
| 114 | MP0002132_abnormal_respiratory_system | 0.88731158 |
| 115 | MP0008438_abnormal_cutaneous_collagen | 0.88262724 |
| 116 | MP0000371_diluted_coat_color | 0.87191785 |
| 117 | MP0005464_abnormal_platelet_physiology | 0.86799976 |
| 118 | MP0009763_increased_sensitivity_to | 0.86222218 |
| 119 | MP0008469_abnormal_protein_level | 0.85810520 |
| 120 | MP0001533_abnormal_skeleton_physiology | 0.84791855 |
| 121 | MP0001835_abnormal_antigen_presentation | 0.83721127 |
| 122 | MP0005076_abnormal_cell_differentiation | 0.83232642 |
| 123 | MP0009278_abnormal_bone_marrow | 0.82677438 |
| 124 | MP0009115_abnormal_fat_cell | 0.82478833 |
| 125 | MP0002419_abnormal_innate_immunity | 0.82426911 |
| 126 | MP0005535_abnormal_body_temperature | 0.82021429 |
| 127 | MP0004858_abnormal_nervous_system | 0.81706804 |
| 128 | MP0005023_abnormal_wound_healing | 0.79651087 |
| 129 | MP0003091_abnormal_cell_migration | 0.77936500 |
| 130 | MP0005390_skeleton_phenotype | 0.77745769 |
| 131 | MP0002295_abnormal_pulmonary_circulatio | 0.77612056 |
| 132 | MP0004185_abnormal_adipocyte_glucose | 0.77091293 |
| 133 | MP0009785_altered_susceptibility_to | 0.76876408 |
| 134 | MP0004808_abnormal_hematopoietic_stem | 0.76517347 |
| 135 | MP0005623_abnormal_meninges_morphology | 0.75856240 |
| 136 | MP0004947_skin_inflammation | 0.74670996 |
| 137 | MP0009780_abnormal_chondrocyte_physiolo | 0.74642721 |
| 138 | MP0001346_abnormal_lacrimal_gland | 0.74636009 |
| 139 | MP0004264_abnormal_extraembryonic_tissu | 0.74620112 |
| 140 | MP0005166_decreased_susceptibility_to | 0.71339138 |
| 141 | MP0010307_abnormal_tumor_latency | 0.70843370 |
| 142 | MP0003866_abnormal_defecation | 0.69106592 |
| 143 | MP0004272_abnormal_basement_membrane | 0.69026698 |
| 144 | MP0001663_abnormal_digestive_system | 0.68748872 |
| 145 | MP0005334_abnormal_fat_pad | 0.68668532 |
| 146 | MP0001879_abnormal_lymphatic_vessel | 0.67322584 |
| 147 | MP0000920_abnormal_myelination | 0.67168166 |
| 148 | MP0003634_abnormal_glial_cell | 0.66884820 |
| 149 | MP0002161_abnormal_fertility/fecundity | 0.66822972 |
| 150 | MP0005375_adipose_tissue_phenotype | 0.66137893 |
| 151 | MP0009643_abnormal_urine_homeostasis | 0.66055534 |
| 152 | MP0003795_abnormal_bone_structure | 0.64577104 |
| 153 | MP0003183_abnormal_peptide_metabolism | 0.64271740 |
| 154 | MP0002928_abnormal_bile_duct | 0.63866159 |
| 155 | MP0001765_abnormal_ion_homeostasis | 0.63649885 |
| 156 | MP0003633_abnormal_nervous_system | 0.63090040 |
| 157 | MP0005164_abnormal_response_to | 0.62492468 |
| 158 | MP0000249_abnormal_blood_vessel | 0.62046326 |
| 159 | MP0000013_abnormal_adipose_tissue | 0.61250779 |
| 160 | MP0002638_abnormal_pupillary_reflex | 0.60443797 |
| 161 | MP0005647_abnormal_sex_gland | 0.58657121 |
| 162 | MP0002092_abnormal_eye_morphology | 0.57539883 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nuclear cataract (HP:0100018) | 9.72394543 |
| 2 | Zonular cataract (HP:0010920) | 9.04074028 |
| 3 | Congenital stationary night blindness (HP:0007642) | 5.23508318 |
| 4 | Pigmentary retinal degeneration (HP:0001146) | 4.98574492 |
| 5 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 4.96432868 |
| 6 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 4.92807371 |
| 7 | Absent/shortened dynein arms (HP:0200106) | 4.92807371 |
| 8 | Recurrent bacterial skin infections (HP:0005406) | 4.72310760 |
| 9 | Eczematoid dermatitis (HP:0000976) | 4.68684103 |
| 10 | Recurrent abscess formation (HP:0002722) | 4.60179172 |
| 11 | Retrobulbar optic neuritis (HP:0100654) | 4.58962356 |
| 12 | Optic neuritis (HP:0100653) | 4.58962356 |
| 13 | Orchitis (HP:0100796) | 4.57179929 |
| 14 | Abnormality of macrophages (HP:0004311) | 4.55936285 |
| 15 | Bony spicule pigmentary retinopathy (HP:0007737) | 4.44930751 |
| 16 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.24556246 |
| 17 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.24556246 |
| 18 | Abnormality of glycolipid metabolism (HP:0010969) | 4.24556246 |
| 19 | Myositis (HP:0100614) | 4.17431714 |
| 20 | Central scotoma (HP:0000603) | 4.05576447 |
| 21 | Chorioretinal atrophy (HP:0000533) | 3.99270492 |
| 22 | Nasal polyposis (HP:0100582) | 3.49562257 |
| 23 | Abnormal rod and cone electroretinograms (HP:0008323) | 3.47776641 |
| 24 | Dyschromatopsia (HP:0007641) | 3.46203195 |
| 25 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.45856090 |
| 26 | Scotoma (HP:0000575) | 3.44332768 |
| 27 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.41319877 |
| 28 | Stomatitis (HP:0010280) | 3.40891237 |
| 29 | Abolished electroretinogram (ERG) (HP:0000550) | 3.33883398 |
| 30 | Abnormality of macular pigmentation (HP:0008002) | 3.23560835 |
| 31 | Keratoconjunctivitis sicca (HP:0001097) | 3.21425567 |
| 32 | Abnormality of the nasal mucosa (HP:0000433) | 3.20684198 |
| 33 | Mediastinal lymphadenopathy (HP:0100721) | 3.18989335 |
| 34 | Dysostosis multiplex (HP:0000943) | 3.18142079 |
| 35 | Vacuolated lymphocytes (HP:0001922) | 3.13686011 |
| 36 | Cone-rod dystrophy (HP:0000548) | 3.02866816 |
| 37 | Congenital cataract (HP:0000519) | 3.02599701 |
| 38 | Retinal atrophy (HP:0001105) | 2.99709303 |
| 39 | Polar cataract (HP:0010696) | 2.98937665 |
| 40 | Gingivitis (HP:0000230) | 2.92786541 |
| 41 | Vasculitis (HP:0002633) | 2.92511312 |
| 42 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.90261904 |
| 43 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.90261904 |
| 44 | Rhinitis (HP:0012384) | 2.90181490 |
| 45 | Recurrent skin infections (HP:0001581) | 2.87017274 |
| 46 | Chronic bronchitis (HP:0004469) | 2.86351576 |
| 47 | Deep venous thrombosis (HP:0002625) | 2.82498079 |
| 48 | Posterior subcapsular cataract (HP:0007787) | 2.82497486 |
| 49 | Keratoconjunctivitis (HP:0001096) | 2.81319160 |
| 50 | Macular degeneration (HP:0000608) | 2.78667465 |
| 51 | Xanthomatosis (HP:0000991) | 2.77716003 |
| 52 | Disinhibition (HP:0000734) | 2.75462808 |
| 53 | Attenuation of retinal blood vessels (HP:0007843) | 2.72298152 |
| 54 | Complement deficiency (HP:0004431) | 2.72008733 |
| 55 | Decreased central vision (HP:0007663) | 2.70712370 |
| 56 | Gastrointestinal infarctions (HP:0005244) | 2.69675965 |
| 57 | Subcapsular cataract (HP:0000523) | 2.67807139 |
| 58 | Choroideremia (HP:0001139) | 2.67344768 |
| 59 | Infertility (HP:0000789) | 2.66556421 |
| 60 | Pulmonary infiltrates (HP:0002113) | 2.62135200 |
| 61 | Recurrent viral infections (HP:0004429) | 2.59319528 |
| 62 | Abnormal ciliary motility (HP:0012262) | 2.56858143 |
| 63 | Anterior segment dysgenesis (HP:0007700) | 2.51627952 |
| 64 | Gingival bleeding (HP:0000225) | 2.45587527 |
| 65 | Recurrent fungal infections (HP:0002841) | 2.44050481 |
| 66 | Arterial thrombosis (HP:0004420) | 2.43812178 |
| 67 | Malnutrition (HP:0004395) | 2.43368582 |
| 68 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.42294643 |
| 69 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.42094778 |
| 70 | Mucopolysacchariduria (HP:0008155) | 2.42094778 |
| 71 | Corneal dystrophy (HP:0001131) | 2.41367318 |
| 72 | Hemoptysis (HP:0002105) | 2.40308965 |
| 73 | Type II diabetes mellitus (HP:0005978) | 2.40114217 |
| 74 | Abnormality of the lower motor neuron (HP:0002366) | 2.38355948 |
| 75 | Intrahepatic cholestasis (HP:0001406) | 2.37982153 |
| 76 | Pendular nystagmus (HP:0012043) | 2.37580412 |
| 77 | Gangrene (HP:0100758) | 2.37493160 |
| 78 | Autoimmune hemolytic anemia (HP:0001890) | 2.36916217 |
| 79 | Meningitis (HP:0001287) | 2.35762598 |
| 80 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.34872475 |
| 81 | Photophobia (HP:0000613) | 2.34297487 |
| 82 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.33919729 |
| 83 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.33919729 |
| 84 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.33919729 |
| 85 | Urticaria (HP:0001025) | 2.32768907 |
| 86 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.30860065 |
| 87 | Amblyopia (HP:0000646) | 2.29582063 |
| 88 | T lymphocytopenia (HP:0005403) | 2.29426378 |
| 89 | Clumsiness (HP:0002312) | 2.28904833 |
| 90 | Obstructive lung disease (HP:0006536) | 2.27019885 |
| 91 | Chronic obstructive pulmonary disease (HP:0006510) | 2.27019885 |
| 92 | Hypercholesterolemia (HP:0003124) | 2.26344910 |
| 93 | Glomerulonephritis (HP:0000099) | 2.25342749 |
| 94 | Abnormality of T cell number (HP:0011839) | 2.22798342 |
| 95 | Neurofibrillary tangles (HP:0002185) | 2.22454698 |
| 96 | Progressive visual loss (HP:0000529) | 2.22434779 |
| 97 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.20657403 |
| 98 | Basal ganglia calcification (HP:0002135) | 2.19709928 |
| 99 | Increased IgM level (HP:0003496) | 2.18454915 |
| 100 | Systemic lupus erythematosus (HP:0002725) | 2.17696020 |
| 101 | Epidermoid cyst (HP:0200040) | 2.17162831 |
| 102 | Increased IgE level (HP:0003212) | 2.16869818 |
| 103 | Hypoalphalipoproteinemia (HP:0003233) | 2.14325666 |
| 104 | Peritonitis (HP:0002586) | 2.13895849 |
| 105 | Myocardial infarction (HP:0001658) | 2.13535702 |
| 106 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.10955520 |
| 107 | Hypobetalipoproteinemia (HP:0003563) | 2.10892173 |
| 108 | Asymmetric septal hypertrophy (HP:0001670) | 2.10065840 |
| 109 | Pulmonary embolism (HP:0002204) | 2.07913062 |
| 110 | Constricted visual fields (HP:0001133) | 2.07383867 |
| 111 | Polyneuropathy (HP:0001271) | 2.07209480 |
| 112 | Recurrent bronchitis (HP:0002837) | 2.06749288 |
| 113 | Encephalitis (HP:0002383) | 2.06678774 |
| 114 | Hypolipoproteinemia (HP:0010981) | 2.05526059 |
| 115 | Purpura (HP:0000979) | 2.05328858 |
| 116 | Hemorrhage of the eye (HP:0011885) | 2.04810099 |
| 117 | Hypergammaglobulinemia (HP:0010702) | 2.04041118 |
| 118 | Abnormality of complement system (HP:0005339) | 2.03372259 |
| 119 | Colitis (HP:0002583) | 1.99422236 |
| 120 | Progressive neurologic deterioration (HP:0002344) | 1.98940100 |
| 121 | Spontaneous hematomas (HP:0007420) | 1.98791166 |
| 122 | Autoimmune thrombocytopenia (HP:0001973) | 1.97777980 |
| 123 | Osteomyelitis (HP:0002754) | 1.96858281 |
| 124 | Episodic fever (HP:0001954) | 1.96690493 |
| 125 | Cerebral inclusion bodies (HP:0100314) | 1.96341750 |
| 126 | Joint swelling (HP:0001386) | 1.96211435 |
| 127 | Increased serum ferritin (HP:0003281) | 1.94899034 |
| 128 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.94710983 |
| 129 | Spastic tetraparesis (HP:0001285) | 1.94332397 |
| 130 | Cholecystitis (HP:0001082) | 1.93778077 |
| 131 | Abnormal gallbladder physiology (HP:0012438) | 1.93778077 |
| 132 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.93667431 |
| 133 | Cellulitis (HP:0100658) | 1.93107437 |
| 134 | Anorexia (HP:0002039) | 1.92224313 |
| 135 | Inflammation of the large intestine (HP:0002037) | 1.91281892 |
| 136 | Glomerulopathy (HP:0100820) | 1.91005039 |
| 137 | Increased cerebral lipofuscin (HP:0011813) | 1.90837815 |
| 138 | Gastrointestinal stroma tumor (HP:0100723) | 1.90092999 |
| 139 | Interstitial pulmonary disease (HP:0006530) | 1.89978104 |
| 140 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.89908875 |
| 141 | Recurrent cutaneous fungal infections (HP:0011370) | 1.89908875 |
| 142 | Retinitis pigmentosa (HP:0000510) | 1.89844094 |
| 143 | Loss of speech (HP:0002371) | 1.87886160 |
| 144 | Upper motor neuron abnormality (HP:0002127) | 1.87866252 |
| 145 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.87741601 |
| 146 | Abnormality of the common coagulation pathway (HP:0010990) | 1.86945275 |
| 147 | Gastrointestinal inflammation (HP:0004386) | 1.86287117 |
| 148 | Abnormality of proline metabolism (HP:0010907) | 1.86235813 |
| 149 | Hydroxyprolinuria (HP:0003080) | 1.86235813 |
| 150 | Mutism (HP:0002300) | 1.86080075 |
| 151 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.86057236 |
| 152 | Axonal loss (HP:0003447) | 1.85894080 |
| 153 | Supranuclear gaze palsy (HP:0000605) | 1.85701407 |
| 154 | Bone pain (HP:0002653) | 1.85471406 |
| 155 | Acne (HP:0001061) | 1.84479954 |
| 156 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.83636328 |
| 157 | Keratoconus (HP:0000563) | 1.82982338 |
| 158 | Increased corneal curvature (HP:0100692) | 1.82982338 |
| 159 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.81177241 |
| 160 | Nephritis (HP:0000123) | 1.80150075 |
| 161 | Petechiae (HP:0000967) | 1.79348397 |
| 162 | Apathy (HP:0000741) | 1.79062819 |
| 163 | Esophageal varix (HP:0002040) | 1.77785097 |
| 164 | Bronchitis (HP:0012387) | 1.77628453 |
| 165 | Neuronal loss in central nervous system (HP:0002529) | 1.76716221 |
| 166 | Spondylolisthesis (HP:0003302) | 1.76623458 |
| 167 | Hyperlipoproteinemia (HP:0010980) | 1.76167539 |
| 168 | Vascular calcification (HP:0004934) | 1.75938153 |
| 169 | Tetraparesis (HP:0002273) | 1.74767844 |
| 170 | Prolonged partial thromboplastin time (HP:0003645) | 1.74716524 |
| 171 | Polycythemia (HP:0001901) | 1.73728580 |
| 172 | Arthralgia (HP:0002829) | 1.73325512 |
| 173 | Lower limb hyperreflexia (HP:0002395) | 1.73102467 |
| 174 | Chronic otitis media (HP:0000389) | 1.72618671 |
| 175 | Abnormality of the endocardium (HP:0004306) | 1.72256039 |
| 176 | Fat malabsorption (HP:0002630) | 1.71622628 |
| 177 | Cardiovascular calcification (HP:0011915) | 1.69085434 |
| 178 | Vitreoretinal degeneration (HP:0000655) | 1.67795712 |
| 179 | Hand muscle atrophy (HP:0009130) | 1.67666186 |
| 180 | Amyloidosis (HP:0011034) | 1.66846712 |
| 181 | Skin nodule (HP:0200036) | 1.66768008 |
| 182 | Recurrent sinusitis (HP:0011108) | 1.65526175 |
| 183 | Hematochezia (HP:0002573) | 1.64405915 |
| 184 | Distal upper limb amyotrophy (HP:0007149) | 1.64394282 |
| 185 | Upper limb amyotrophy (HP:0009129) | 1.64394282 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PDK3 | 4.33580809 |
| 2 | PDK4 | 4.33580809 |
| 3 | IRAK3 | 3.31511689 |
| 4 | PDK2 | 3.18591191 |
| 5 | TESK1 | 2.86041808 |
| 6 | PRKD3 | 2.71718246 |
| 7 | IRAK4 | 2.42673254 |
| 8 | PRPF4B | 2.32794663 |
| 9 | ICK | 2.19548353 |
| 10 | WNK4 | 2.16009454 |
| 11 | STK39 | 2.14820363 |
| 12 | TRIB3 | 2.09229722 |
| 13 | ERN1 | 2.07397849 |
| 14 | PTK2B | 2.02936820 |
| 15 | BMPR2 | 2.02034610 |
| 16 | NLK | 1.98527316 |
| 17 | GRK7 | 1.91537084 |
| 18 | MAP3K3 | 1.90395964 |
| 19 | EPHB1 | 1.85881126 |
| 20 | RIPK1 | 1.79494968 |
| 21 | TBK1 | 1.79014357 |
| 22 | MAP4K1 | 1.78419252 |
| 23 | MATK | 1.78371933 |
| 24 | TAOK1 | 1.76238306 |
| 25 | MAP2K3 | 1.75114704 |
| 26 | GRK1 | 1.74540485 |
| 27 | RIPK4 | 1.74234750 |
| 28 | TYK2 | 1.66630270 |
| 29 | PTK6 | 1.65895441 |
| 30 | TAOK2 | 1.65267546 |
| 31 | CAMK1G | 1.61984327 |
| 32 | JAK1 | 1.60080295 |
| 33 | SIK1 | 1.48297645 |
| 34 | MST1R | 1.47816566 |
| 35 | MAP3K11 | 1.35796949 |
| 36 | ZAP70 | 1.35769407 |
| 37 | IKBKB | 1.35664654 |
| 38 | FGFR4 | 1.35180489 |
| 39 | CAMK1D | 1.30641408 |
| 40 | MOS | 1.30617862 |
| 41 | CAMKK1 | 1.29114485 |
| 42 | MAPK7 | 1.27223847 |
| 43 | FRK | 1.27200394 |
| 44 | WNK1 | 1.26577267 |
| 45 | NME2 | 1.25476113 |
| 46 | CDC42BPA | 1.24826879 |
| 47 | MAP3K14 | 1.16810517 |
| 48 | ACVR1B | 1.15178939 |
| 49 | STK10 | 1.12991291 |
| 50 | PBK | 1.12870617 |
| 51 | TAOK3 | 1.12004918 |
| 52 | PDK1 | 1.09560713 |
| 53 | PDPK1 | 1.02168515 |
| 54 | MAP3K1 | 1.00512763 |
| 55 | IKBKE | 1.00324235 |
| 56 | NEK9 | 0.99840670 |
| 57 | SYK | 0.97349923 |
| 58 | HCK | 0.97187321 |
| 59 | PKN2 | 0.95351818 |
| 60 | BTK | 0.93077288 |
| 61 | MAP3K13 | 0.92124029 |
| 62 | NTRK1 | 0.91007714 |
| 63 | MARK3 | 0.90924718 |
| 64 | LMTK2 | 0.89728331 |
| 65 | PAK6 | 0.88032252 |
| 66 | KSR2 | 0.87969995 |
| 67 | SGK2 | 0.87875784 |
| 68 | SIK3 | 0.87697906 |
| 69 | MAP3K5 | 0.86079461 |
| 70 | LYN | 0.85485279 |
| 71 | STK38 | 0.82716978 |
| 72 | CDK4 | 0.81444280 |
| 73 | TXK | 0.80848769 |
| 74 | BMX | 0.79620727 |
| 75 | PDGFRA | 0.79356428 |
| 76 | INSRR | 0.78847615 |
| 77 | DYRK1B | 0.77514434 |
| 78 | IRAK2 | 0.77255972 |
| 79 | PRKCH | 0.75763938 |
| 80 | MAP3K2 | 0.74000212 |
| 81 | CDK3 | 0.71284659 |
| 82 | MET | 0.69937422 |
| 83 | JAK2 | 0.69730167 |
| 84 | RET | 0.68768872 |
| 85 | YES1 | 0.68484872 |
| 86 | MAPK15 | 0.67803129 |
| 87 | SGK1 | 0.67290080 |
| 88 | CSK | 0.66316858 |
| 89 | FGFR3 | 0.64699276 |
| 90 | DAPK2 | 0.64422959 |
| 91 | TTN | 0.63564374 |
| 92 | JAK3 | 0.63083977 |
| 93 | BMPR1B | 0.62621812 |
| 94 | LCK | 0.61886947 |
| 95 | PTK2 | 0.61464760 |
| 96 | KIT | 0.60889985 |
| 97 | PINK1 | 0.58806351 |
| 98 | MAP2K2 | 0.58779067 |
| 99 | FER | 0.58617571 |
| 100 | PDGFRB | 0.57968666 |
| 101 | EGFR | 0.56381882 |
| 102 | PRKCZ | 0.56274959 |
| 103 | MAP3K10 | 0.56264929 |
| 104 | LRRK2 | 0.56097412 |
| 105 | PRKAA2 | 0.55611680 |
| 106 | TYRO3 | 0.55139545 |
| 107 | MAP3K9 | 0.54778573 |
| 108 | TIE1 | 0.53124274 |
| 109 | CLK1 | 0.52346211 |
| 110 | ARAF | 0.51665212 |
| 111 | MAP3K12 | 0.50587411 |
| 112 | TGFBR2 | 0.48991945 |
| 113 | TRPM7 | 0.48784880 |
| 114 | PAK2 | 0.48602120 |
| 115 | MELK | 0.47717470 |
| 116 | MAP2K6 | 0.47668420 |
| 117 | IRAK1 | 0.46824333 |
| 118 | PRKACG | 0.46341574 |
| 119 | CDK12 | 0.45901852 |
| 120 | CHUK | 0.45858008 |
| 121 | IGF1R | 0.45594225 |
| 122 | TEC | 0.45407183 |
| 123 | CDK6 | 0.43613103 |
| 124 | PRKAA1 | 0.43458409 |
| 125 | STK3 | 0.43296917 |
| 126 | DDR2 | 0.42963482 |
| 127 | MST4 | 0.42888455 |
| 128 | PIM1 | 0.42574383 |
| 129 | STK24 | 0.42540564 |
| 130 | MAP2K1 | 0.42440568 |
| 131 | PRKCQ | 0.42318821 |
| 132 | MAP3K8 | 0.41199903 |
| 133 | SGK3 | 0.41186840 |
| 134 | ERBB2 | 0.40771400 |
| 135 | SGK223 | 0.39579126 |
| 136 | SGK494 | 0.39579126 |
| 137 | BLK | 0.39455818 |
| 138 | PKN1 | 0.39293668 |
| 139 | GSK3A | 0.39281977 |
| 140 | NEK6 | 0.38767074 |
| 141 | CSF1R | 0.38600102 |
| 142 | KDR | 0.37786673 |
| 143 | FES | 0.37291176 |
| 144 | ERBB4 | 0.37082593 |
| 145 | TNK2 | 0.36917072 |
| 146 | GRK6 | 0.36427244 |
| 147 | EIF2AK3 | 0.36009132 |
| 148 | MAPK11 | 0.35424309 |
| 149 | MARK2 | 0.35397378 |
| 150 | FGR | 0.34269121 |
| 151 | PAK3 | 0.33931452 |
| 152 | HIPK2 | 0.33866348 |
| 153 | MAP2K4 | 0.33108734 |
| 154 | PIM2 | 0.32485929 |
| 155 | KSR1 | 0.32428858 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phototransduction_Homo sapiens_hsa04744 | 4.54847535 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.76240258 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.49695647 |
| 4 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.36039348 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.27898456 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.26427055 |
| 7 | Other glycan degradation_Homo sapiens_hsa00511 | 2.26028114 |
| 8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.21993960 |
| 9 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.08385815 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.01209385 |
| 11 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.98184937 |
| 12 | Measles_Homo sapiens_hsa05162 | 1.91904781 |
| 13 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.90687376 |
| 14 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.83855626 |
| 15 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.81453334 |
| 16 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.75659967 |
| 17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.72857430 |
| 18 | Asthma_Homo sapiens_hsa05310 | 1.72331768 |
| 19 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.71303483 |
| 20 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.70393374 |
| 21 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.64107392 |
| 22 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.63252453 |
| 23 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.59881996 |
| 24 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.57735129 |
| 25 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.56723510 |
| 26 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.56395515 |
| 27 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.51321314 |
| 28 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.49730275 |
| 29 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.48458815 |
| 30 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.46308255 |
| 31 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.39420028 |
| 32 | Bile secretion_Homo sapiens_hsa04976 | 1.39154681 |
| 33 | Hepatitis B_Homo sapiens_hsa05161 | 1.37704704 |
| 34 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.37255268 |
| 35 | ABC transporters_Homo sapiens_hsa02010 | 1.35792254 |
| 36 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.31976131 |
| 37 | Retinol metabolism_Homo sapiens_hsa00830 | 1.31448445 |
| 38 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.30902093 |
| 39 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.30034713 |
| 40 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.24285725 |
| 41 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.23890930 |
| 42 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.23871460 |
| 43 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.23844423 |
| 44 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.23631650 |
| 45 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.22638605 |
| 46 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.20941126 |
| 47 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.20419496 |
| 48 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.20175162 |
| 49 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.20174645 |
| 50 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.16690613 |
| 51 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.14826125 |
| 52 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.14343544 |
| 53 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.13311383 |
| 54 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.10441847 |
| 55 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.08612220 |
| 56 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.08219413 |
| 57 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.06962793 |
| 58 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.06842626 |
| 59 | Shigellosis_Homo sapiens_hsa05131 | 1.06438353 |
| 60 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.05951770 |
| 61 | Viral myocarditis_Homo sapiens_hsa05416 | 1.04859242 |
| 62 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.02178983 |
| 63 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.97180723 |
| 64 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.96845516 |
| 65 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.94931170 |
| 66 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.94358571 |
| 67 | Apoptosis_Homo sapiens_hsa04210 | 0.88891454 |
| 68 | Mineral absorption_Homo sapiens_hsa04978 | 0.86005326 |
| 69 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.81401306 |
| 70 | Histidine metabolism_Homo sapiens_hsa00340 | 0.80644151 |
| 71 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.78313937 |
| 72 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.76471642 |
| 73 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.76447164 |
| 74 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.75523593 |
| 75 | Peroxisome_Homo sapiens_hsa04146 | 0.75220760 |
| 76 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.74911519 |
| 77 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.74297621 |
| 78 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.73629348 |
| 79 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.72774110 |
| 80 | Renin secretion_Homo sapiens_hsa04924 | 0.71053344 |
| 81 | Insulin resistance_Homo sapiens_hsa04931 | 0.70758941 |
| 82 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.69649518 |
| 83 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.68791138 |
| 84 | Lysosome_Homo sapiens_hsa04142 | 0.68552066 |
| 85 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.68370719 |
| 86 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.67549445 |
| 87 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.67387247 |
| 88 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.66578753 |
| 89 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.65748594 |
| 90 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.63268546 |
| 91 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.62417572 |
| 92 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.62040811 |
| 93 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.62011493 |
| 94 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.60994155 |
| 95 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.60849212 |
| 96 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.59963364 |
| 97 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.59731559 |
| 98 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.58835103 |
| 99 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.58804270 |
| 100 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.57862678 |
| 101 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.56949760 |
| 102 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.56825024 |
| 103 | Prion diseases_Homo sapiens_hsa05020 | 0.55687013 |
| 104 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.54485432 |
| 105 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.53498549 |
| 106 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.53296765 |
| 107 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.53288840 |
| 108 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.52978791 |
| 109 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.52511225 |
| 110 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.52481886 |
| 111 | Platelet activation_Homo sapiens_hsa04611 | 0.51683385 |
| 112 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.51569488 |
| 113 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.51163280 |
| 114 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.50372628 |
| 115 | Bladder cancer_Homo sapiens_hsa05219 | 0.50003724 |
| 116 | Prostate cancer_Homo sapiens_hsa05215 | 0.48989189 |
| 117 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.48507480 |
| 118 | Carbon metabolism_Homo sapiens_hsa01200 | 0.48057303 |
| 119 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.47136199 |
| 120 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.45874172 |
| 121 | Amoebiasis_Homo sapiens_hsa05146 | 0.45675842 |
| 122 | Leishmaniasis_Homo sapiens_hsa05140 | 0.45478581 |
| 123 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.44961078 |
| 124 | Legionellosis_Homo sapiens_hsa05134 | 0.44549219 |
| 125 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.44036184 |
| 126 | Pertussis_Homo sapiens_hsa05133 | 0.43326791 |
| 127 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.43285580 |
| 128 | Phagosome_Homo sapiens_hsa04145 | 0.41290749 |
| 129 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.40978633 |
| 130 | Tuberculosis_Homo sapiens_hsa05152 | 0.40479451 |
| 131 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.40198323 |
| 132 | Olfactory transduction_Homo sapiens_hsa04740 | 0.39993943 |
| 133 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.39953718 |
| 134 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.39367995 |
| 135 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.38182195 |
| 136 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.38061961 |
| 137 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.38004583 |
| 138 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.37577944 |
| 139 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.37392958 |
| 140 | Salmonella infection_Homo sapiens_hsa05132 | 0.37390587 |
| 141 | Influenza A_Homo sapiens_hsa05164 | 0.37244924 |
| 142 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.37080978 |
| 143 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.36410290 |
| 144 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.36216050 |
| 145 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.35970864 |
| 146 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.35891108 |
| 147 | Galactose metabolism_Homo sapiens_hsa00052 | 0.35591679 |
| 148 | Malaria_Homo sapiens_hsa05144 | 0.35148739 |
| 149 | HTLV-I infection_Homo sapiens_hsa05166 | 0.34986578 |
| 150 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.34662349 |
| 151 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.34402889 |
| 152 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.34330758 |
| 153 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.33920619 |
| 154 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.33762453 |
| 155 | Lysine degradation_Homo sapiens_hsa00310 | 0.33565559 |
| 156 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.33475921 |
| 157 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.32418370 |
| 158 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.31851011 |
| 159 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.31103151 |
| 160 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.30653501 |
| 161 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.30267400 |
| 162 | Endometrial cancer_Homo sapiens_hsa05213 | 0.29574829 |
| 163 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.29310955 |
| 164 | Hepatitis C_Homo sapiens_hsa05160 | 0.29288185 |
| 165 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.28616955 |
| 166 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.28144910 |
| 167 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.27892018 |
| 168 | Endocytosis_Homo sapiens_hsa04144 | 0.27755729 |

